Heparin-induced conformational change in microtubule-associated protein tau as detected by chemical cross-linking and phosphopeptide mapping

被引:75
作者
Paudel, HK
Li, W
机构
[1] Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada
[3] Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada
关键词
D O I
10.1074/jbc.274.12.8029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Alzheimer's disease, microtubule-associated protein tau becomes abnormally phosphorylated and aggregates into paired helical filaments. Sulfated glycosaminoglycans such as heparin and heparan sulfate were shown to accumulate in pretangle neurons, stimulate in vitro tau phosphorylation, and cause tan aggregation into paired helical filament-like filaments. The sulfated glycosaminoglycan-tau interaction was suggested to be the central event in the development of neuropathology in Alzheimer's disease brain (Goedert, M,, Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., and Crowther, R, A. (1996) Nature 383, 550-553), The biochemical mechanism by which sulfated glycosaminoglycans stimulate tau phosphorylation and cause tan aggregation remains unclear. In this study, disuccinimidyl suberate (DSS), a bifunctional chemical cross-linker, cross-linked tau dimers, tetramers, high molecular size aggregates, and two tau species of sizes 72 and 83 kDa in the presence of heparin, In the absence of heparin only dimeric tau was cross-linked by DSS, Fast protein liquid chromatography gel filtration revealed that 72- and 83-kDa species were formed by intramolecular cross-linking of tau by DSS, These observations indicate that heparin, in addition to causing aggregation, also induces a conformational change in tau in which reactive groups are unmasked or move closer leading to the DSS crosslinking of 72- and 83-kDa species. Heparin-induced structural changes in tau molecule depended on time of heparin exposure. Dimerization and tetramerization peaked at 48 h, whereas conformational change was completed within 30 min of heparin exposure. Heparin exposure beyond 48 h caused an abrupt aggregation of tau into high molecular size species. Heparin stimulated tau phosphorylation by neuronal cdc2-like kinase (NCLK) and cAMP-dependent protein kinase, Phosphopeptide mapping and phosphopeptide sequencing revealed that tau is phosphorylated by NCLK on Thr(212) and Thr(231) and by cAMP-dependent protein kinase on Ser(262) only in the presence of heparin, Heparin stimulation of tau phosphorylation by NCLK showed dependence on time of heparin exposure and correlated with the heparin-induced conformational change of tau, Our data suggest that heparin-induced conformational change exposes new sites for phosphorylation within tau molecule.
引用
收藏
页码:8029 / 8038
页数:10
相关论文
共 45 条
[21]  
LEW J, 1992, J BIOL CHEM, V267, P13383
[22]   Lan protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356 [J].
Litersky, JM ;
Johnson, GVW ;
Jakes, R ;
Goedert, M ;
Lee, M ;
Seubert, P .
BIOCHEMICAL JOURNAL, 1996, 316 :655-660
[23]   GLYCOGEN-SYNTHASE KINASE-3 AND THE ALZHEIMER-LIKE STATE OF MICROTUBULE-ASSOCIATED PROTEIN TAU [J].
MANDELKOW, EM ;
DREWES, G ;
BIERNAT, J ;
GUSTKE, N ;
VANLINT, J ;
VANDENHEEDE, JR ;
MANDELKOW, E .
FEBS LETTERS, 1992, 314 (03) :315-321
[24]  
MAWALDEWAN M, 1992, J BIOL CHEM, V267, P19705
[25]   PROLINE-DIRECTED AND NON-PROLINE-DIRECTED PHOSPHORYLATION OF PHF-TAU [J].
MORISHIMAKAWASHIMA, M ;
HASEGAWA, M ;
TAKIO, K ;
SUZUKI, M ;
YOSHIDA, H ;
TITANI, K ;
IHARA, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (02) :823-829
[26]   Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of tau protein in vitro [J].
Paudel, HK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28328-28334
[27]  
Paudel HK, 1997, J BIOL CHEM, V272, P1777
[28]  
PAUDEL HK, 1993, J BIOL CHEM, V268, P23512
[29]  
PERRY G, 1991, J NEUROSCI, V11, P3679
[30]  
Reynolds CH, 1997, J NEUROCHEM, V69, P191